Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 686921, 12 pages
http://dx.doi.org/10.1155/2014/686921
Review Article

Pomegranate Fruit as a Rich Source of Biologically Active Compounds

Cancer Research Program, Rajiv Gandhi Centre for Biotechnology, Thycaud P.O, Thiruvananthapuram, Kerala 695 014, India

Received 21 November 2013; Revised 25 February 2014; Accepted 25 February 2014; Published 10 April 2014

Academic Editor: Kota V. Ramana

Copyright © 2014 Sreeja Sreekumar et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. G. Miguel, M. A. Neves, and M. D. Antunes, “Pomegranate (Punica granatum L.): a medicinal plant with myriad biological properties—a short review,” Journal of Medicinal Plant Research, vol. 4, no. 25, pp. 2836–2847, 2010. View at Google Scholar · View at Scopus
  2. M. I. Elghamry and I. M. Shihata, “Biological activity of phytoestrogens. 3. Experimental studies on some biological properties of beta-sitosterol,” Planta Medica, vol. 14, no. 3, pp. 352–357, 1966. View at Google Scholar · View at Scopus
  3. P. J. Magee and I. R. Rowland, “Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer,” The British Journal of Nutrition, vol. 91, no. 4, pp. 513–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Barnes, “Phytoestrogens and breast cancer,” Bailliere's Clinical Endocrinology and Metabolism, vol. 12, no. 4, pp. 559–579, 1998. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Adlercreutz, “Phyto-oestrogens and cancer,” The Lancet Oncology, vol. 3, no. 6, pp. 364–373, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. M. G. Glazier and M. A. Bowman, “A review of the evidence for the use of phytoestrogens as a replacement for traditional estrogen replacement therapy,” Archives of Internal Medicine, vol. 161, no. 9, pp. 1161–1172, 2001. View at Google Scholar · View at Scopus
  7. A. Brzezinski and A. Debi, “Phytoestrogens: the “natural” selective estrogen receptor modulators?” European Journal of Obstetrics Gynecology and Reproductive Biology, vol. 85, no. 1, pp. 47–51, 1999. View at Publisher · View at Google Scholar · View at Scopus
  8. U. Halbreich and L. S. Kahn, “Selective oestrogen receptor modulators current and future brain and behaviour applications,” Expert Opinion on Pharmacotherapy, vol. 1, no. 7, pp. 1385–1398, 2000. View at Google Scholar · View at Scopus
  9. T. Hol, M. B. Cox, H. U. Bryant, and M. W. Draper, “Selective estrogen receptor modulators and postmenopausal women's health,” Journal of Women's Health, vol. 6, no. 5, pp. 523–531, 1997. View at Google Scholar · View at Scopus
  10. J. Sierens, J. A. Hartley, M. J. Campbell, A. J. C. Leathem, and J. V. Woodside, “Effect of phytoestrogen and antioxidant supplementation on oxidative DNA damage assessed using the comet assay,” Mutation Research: DNA Repair, vol. 485, no. 2, pp. 169–176, 2001. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Fadavi, M. Barzegar, M. H. Azizi, and M. Bayat, “Physicochemical composition of ten pomegranate cultivars (Punica granatum L.) grown in Iran,” Food Science and Technology International, vol. 11, no. 2, pp. 113–119, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. M. Viuda-Martos, J. Fernández-Lóaez, and J. A. Pérez-álvarez, “Pomegranate and its many functional components as related to human health: a review,” Comprehensive Reviews in Food Science and Food Safety, vol. 9, no. 6, pp. 635–654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. W. Elfalleh, H. Hannachi, N. Tlili, Y. Yahia, N. Nasri, and A. Ferchichi, “Total phenolic contents and antioxidant activities of pomegranate peel, seed, leaf and flower,” Journal of Medicinal Plants Research, vol. 6, no. 32, pp. 4724–4730, 2012. View at Google Scholar
  14. H. Kohno, R. Suzuki, Y. Yasui, M. Hosokawa, K. Miyashita, and T. Tanaka, “Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats,” Cancer Science, vol. 95, no. 6, pp. 481–486, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. E. P. Lansky and R. A. Newman, “Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer,” Journal of Ethnopharmacology, vol. 109, no. 2, pp. 177–206, 2007. View at Publisher · View at Google Scholar · View at Scopus
  16. V. Monica, H. Raquel L Pinyi, and B. R. Josep, “Preventive and prophylactic mechanisms of action of pomegranate bioactive constituents,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 789764, 18 pages, 2013. View at Publisher · View at Google Scholar
  17. W. Elfalleh, N. Tlili, N. Nasri et al., “Antioxidant capacities of phenolic compounds and tocopherols from tunisian pomegranate (Punica granatum) fruits,” Journal of Food Science, vol. 76, no. 5, pp. C707–C713, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Jain, R. Rai, A. R. Upadhyaya, and G. Malhotra, “Punica granatum: a natural and recent approach towards dental problem,” International Journal of Pharmaceutical Sciences and Research, vol. 2, no. 1, pp. 1–6, 2014. View at Google Scholar
  19. N. P. Seeram and M. G. Nair, “Inhibition of lipid peroxidation and structure-activity-related studies of the dietary constituents anthocyanins, anthocyanidins, and catechins,” Journal of Agricultural and Food Chemistry, vol. 50, no. 19, pp. 5308–5312, 2002. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Amakura, M. Okada, S. Tsuji, and Y. Tonogai, “Determination of phenolic acids in fruit juices by isocratic column liquid chromatography,” Journal of Chromatography A, vol. 891, no. 1, pp. 183–188, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. T. Tanaka, G.-I. Nonaka, and I. Nishioka, “Tannins and related compounds. XL. Revision of the structures of punicalin and punicalagin, and isolation and characterization of 2-O-galloylpunicalin from the bark of Punica granatum L,” Chemical and Pharmaceutical Bulletin, vol. 34, no. 2, pp. 650–655, 1986. View at Google Scholar · View at Scopus
  22. M. I. Gil, F. A. Tomas-Barberan, B. Hess-Pierce, D. M. Holcroft, and A. A. Kader, “Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing,” Journal of Agricultural and Food Chemistry, vol. 48, no. 10, pp. 4581–4589, 2000. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Neuhofer, L. Witte, M. Gorunovic, and F.-C. Czygan, “Alkaloids in the bark of Punica granatum L. (Pomegranate) from Yugoslavia,” Die Pharmazie, vol. 48, no. 5, pp. 389–391, 1993. View at Google Scholar · View at Scopus
  24. A. Vidal, A. Fallarero, B. R. Peña et al., “Studies on the toxicity of Punica granatum L. (Punicaceae) whole fruit extracts,” Journal of Ethnopharmacology, vol. 89, no. 2-3, pp. 295–300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. D. A. van Elswijk, U. P. Schobel, E. P. Lansky, H. Irth, and J. van der Greef, “Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry,” Phytochemistry, vol. 65, no. 2, pp. 233–241, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. N. Artik, B. Ceremroglu, H. Murakami, and T. Mori, “Determination of phenolic compounds in pomegranate juice by using HPLC,” Fruit Processing, vol. 8, pp. 492–499, 1998. View at Google Scholar
  27. S.-M. Cui, Y. Sasada, H. Sato, and N. Nii, “Cell structure and sugar and acid contents in the arils of developing pomegranate fruit,” Journal of the Japanese Society for Horticultural Science, vol. 73, no. 3, pp. 241–243, 2004. View at Google Scholar · View at Scopus
  28. E. Poyrazoǧlu, V. Gökmen, and N. Artik, “Organic acids and phenolic compounds in pomegranates (Punica granatum L.) grown in Turkey,” Journal of Food Composition and Analysis, vol. 15, no. 5, pp. 567–575, 2002. View at Publisher · View at Google Scholar · View at Scopus
  29. C. T. Du, P. L. Wang, and F. J. Francis, “Anthocyanins of Pomegranate, Punica granatum,” Journal of Food Science, vol. 40, no. 2, pp. 417–418, 1975. View at Google Scholar
  30. S. Waheed, N. Siddique, A. Rahman, J. H. Zaidi, and S. Ahmad, “INAA for dietary assessment of essential and other trace elements in fourteen fruits harvested and consumed in Pakistan,” Journal of Radioanalytical and Nuclear Chemistry, vol. 260, no. 3, pp. 523–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. T. H. W. Huang, G. Peng, B. P. Kota et al., “Anti-diabetic action of Punica granatum flower extract: activation of PPAR-γ and identification of an active component,” Toxicology and Applied Pharmacology, vol. 207, no. 2, pp. 160–169, 2005. View at Publisher · View at Google Scholar · View at Scopus
  32. A. K. Batta and S. Rangaswami, “Crystalline chemical components of some vegetable drugs,” Phytochemistry, vol. 12, no. 1, pp. 214–216, 1973. View at Google Scholar
  33. J. Lan, F. Lei, L. Hua, Y. Wang, D. Xing, and L. Du, “Transport behavior of ellagic acid of pomegranate leaf tannins and its correlation with total cholesterol alteration in HepG2 cells,” Biomedical Chromatography, vol. 23, no. 5, pp. 531–536, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. H. Chaitra, M. Madhuri, T. Swaroop, D. Arijit, B. Sourav, and K. C. Rohit, “Evaluation of antimicrobial properties, phytochemical contents and antioxidant capacity of leaf extracts of Punica granatum L,” Journal of Biological Sciences, vol. 1, pp. 32–37, 2012. View at Google Scholar
  35. M. A. M. Nawwar, S. A. M. Hussein, and I. Merfort, “Leaf phenolics of Punica granatum,” Phytochemistry, vol. 37, no. 4, pp. 1175–1177, 1994. View at Publisher · View at Google Scholar · View at Scopus
  36. R.-F. Wang, W.-D. Xie, Z. Zhang et al., “Bioactive compounds from the seeds of Punica granatum (pomegranate),” Journal of Natural Products, vol. 67, no. 12, pp. 2096–2098, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. S. Y. Schubert, E. P. Lansky, and I. Neeman, “Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids,” Journal of Ethnopharmacology, vol. 66, no. 1, pp. 11–17, 1999. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Hornung, C. Pernstich, and I. Feussner, “Formation of conjugated Δ11 Δ13-double bonds by Δ12-linoleic acid (1,4)-acyl-lipid-desaturase in pomegranate seeds,” European Journal of Biochemistry, vol. 269, no. 19, pp. 4852–4859, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. S. M. Abd El Wahab, N. M. El Fiki, S. F. Mostafa, and A. E. B. Hassan, “Characterization of certain steroid hormones in Punica granatum L. seeds,” Bulletin of the Faculty of Pharmacy, vol. 36, pp. 11–15, 1998. View at Google Scholar
  40. N. D. Kim, R. Mehta, W. Yu et al., “Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer,” Breast Cancer Research and Treatment, vol. 71, no. 3, pp. 203–217, 2002. View at Publisher · View at Google Scholar · View at Scopus
  41. E. P. Lansky, W. Jiang, H. Mo et al., “Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions,” Investigational New Drugs, vol. 23, no. 1, pp. 11–20, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Jurenka, “Therapeutic applications of pomegranate (Punica granatum L.): a review,” Alternative Medicine Review, vol. 13, no. 2, pp. 128–144, 2008. View at Google Scholar · View at Scopus
  43. A. R. Neurath, N. Strick, Y.-Y. Li, and A. K. Debnath, “Punica granatum (Pomegranate) juice provides an HIV-1 entry inhibitor and candidate topical microbicide,” BMC Infectious Diseases, vol. 4, article 41, 2004. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Toi, H. Bando, C. Ramachandran et al., “Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo,” Angiogenesis, vol. 6, no. 2, pp. 121–128, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. R. Mehta and E. P. Lansky, “Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture,” European Journal of Cancer Prevention, vol. 13, no. 4, pp. 345–348, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. M. A. L. Jeune, J. Kumi-Diaka, and J. Brown, “Anticancer activities of pomegranate extracts and genistein in human breast cancer cells,” Journal of Medicinal Food, vol. 8, no. 4, pp. 469–475, 2005. View at Publisher · View at Google Scholar · View at Scopus
  47. A. Faria and C. Conceição, “The bioactivity of pomegranate: impact on health and disease,” Critical Reviews in Food Science and Nutrition, vol. 51, no. 7, pp. 626–634, 2011. View at Publisher · View at Google Scholar · View at Scopus
  48. L. Wang, A. Alcon, H. Yuan, J. Ho, Q.-J. Li, and M. Martins-Green, “Cellular and molecular mechanisms of pomegranate juice-induced anti-metastatic effect on prostate cancer cells,” Integrative Biology, vol. 3, no. 7, pp. 742–754, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. A. Burton, “Chemoprevention: eat ginger, rub on pomegranate,” The Lancet Oncology, vol. 4, no. 12, p. 715, 2003. View at Google Scholar · View at Scopus
  50. V. M. Adhami, I. A. Siddiqui, D. N. Syed, R. K. Lall, and H. Mukhtar, “Oral infusion of pomegranate fruit extract inhibits prostate carcinogenesis in the TRAMP model,” Carcinogenesis, vol. 33, no. 3, pp. 644–651, 2012. View at Publisher · View at Google Scholar · View at Scopus
  51. L. Herszényi, I. Hritz, G. Lakatos, M. Z. Varga, and Z. Tulassay, “The behavior of matrix metalloproteinases and their inhibitors in colorectal cancer,” International Journal of Molecular Sciences, vol. 13, no. 10, pp. 13240–13263, 2012. View at Google Scholar
  52. F. H. Sarkar, Y. Li, Z. Wang, and D. Kong, “Cellular signaling perturbation by natural products,” Cellular Signalling, vol. 21, no. 11, pp. 1541–1547, 2009. View at Publisher · View at Google Scholar · View at Scopus
  53. S. Sreeja, T. R. Santhosh Kumar, B. S. Lakshmi, and S. Sreeja, “Pomegranate extract demonstrate a selective estrogen receptor modulator profile in human tumor cell lines and in vivo models of estrogen deprivation,” The Journal of Nutritional Biochemistry, vol. 23, no. 7, pp. 725–732, 2012. View at Publisher · View at Google Scholar · View at Scopus
  54. N. Etique, I. Grillier-Vuissoz, and S. Flament, “Ethanol stimulates the secretion of matrix metalloproteinases 2 and 9 in MCF-7 human breast cancer cells,” Oncology Reports, vol. 15, no. 3, pp. 603–608, 2006. View at Google Scholar · View at Scopus
  55. F. Afaq, A. Malik, D. Syed, D. Maes, M. S. Matsui, and H. Mukhtar, “Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes,” Photochemistry and Photobiology, vol. 81, no. 1, pp. 38–45, 2005. View at Publisher · View at Google Scholar · View at Scopus
  56. L. S. Adams, N. P. Seeram, B. B. Aggarwal, Y. Takada, D. Sand, and D. Heber, “Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells,” Journal of Agricultural and Food Chemistry, vol. 54, no. 3, pp. 980–985, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. S. Koyama, L. J. Cobb, H. H. Mehta et al., “Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis,” Growth Hormone and IGF Research, vol. 20, no. 1, pp. 55–62, 2010. View at Publisher · View at Google Scholar · View at Scopus
  58. B. Fuhrman, N. Volkova, and M. Aviram, “Pomegranate juice polyphenols increase recombinant paraoxonase-1 binding to high-density lipoprotein: studies in vitro and in diabetic patients,” Nutrition, vol. 26, no. 4, pp. 359–366, 2010. View at Publisher · View at Google Scholar · View at Scopus
  59. F. de Nigris, S. Williams-Ignarro, L. O. Lerman et al., “Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 13, pp. 4896–4901, 2005. View at Publisher · View at Google Scholar · View at Scopus
  60. M. Aviram, M. Rosenblat, D. Gaitini et al., “Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation,” Clinical Nutrition, vol. 23, no. 3, pp. 423–433, 2004. View at Publisher · View at Google Scholar · View at Scopus
  61. K. M. Azadzoi, R. N. Schulman, M. Aviram, and M. B. Siroky, “Oxidative stress in arteriogenic erectile dysfunction: prophylactic role of antioxidants,” The Journal of Urology, vol. 174, no. 1, pp. 386–393, 2005. View at Publisher · View at Google Scholar · View at Scopus
  62. A. Esmaillzadeh, F. Tahbaz, I. Gaieni, H. Alavi-Majd, and L. Azadbakht, “Cholesterol-lowering effect of concentrated pomegranate juice consumption in type II diabetic patients with hyperlipidemia,” International Journal for Vitamin and Nutrition Research, vol. 76, no. 3, pp. 147–151, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. M. Aviram, N. Volkova, R. Coleman et al., “Pomegranate phenolics from the peels, arils, and flowers are antiatherogenic: studies in vivo in atherosclerotic apolipoprotein E-deficient (E°) mice and in vitro in cultured macrophages and lipoproteins,” Journal of Agricultural and Food Chemistry, vol. 56, no. 3, pp. 1148–1157, 2008. View at Publisher · View at Google Scholar · View at Scopus
  64. V. C. Jordan, E. Phelps, and J. U. Lindgren, “Effects of anti-estrogens on bone in castrated and intact female rats,” Breast Cancer Research and Treatment, vol. 10, no. 1, pp. 31–35, 1987. View at Google Scholar · View at Scopus
  65. H. Z. Ke, V. M. Paralkak, W. A. Grasser et al., “Effects of CP-336,156, a new, nonsteroidal estrogen agonist/antagonist, on bone, serum cholesterol, uterus, and body composition in rat models,” Endocrinology, vol. 139, no. 4, pp. 2068–2076, 1998. View at Google Scholar · View at Scopus
  66. L. J. Lerner and V. C. Jordan, “Development of antiestrogens and their use in breast cancer: eighth cain memorial award lecture,” Cancer Research, vol. 50, no. 14, pp. 4177–4189, 1990. View at Google Scholar · View at Scopus
  67. J. Banu, “The ovariectomized mice and rats,” Osteoporosis Research, SpringerLondon, 2011. View at Google Scholar
  68. S. Sreekumar, Selective estrogen receptor modulator (SERM) activity of Pomegranate (Punica granatum L.): implications for estrogen dependant breast cancer [dissertation], University of Kerala, 2011.
  69. Y.-Y. Kim, S.-H. Kim, S. Oh et al., “Increased fat due to estrogen deficiency induces bone loss by elevating monocyte chemoattractant protein-1 (MCP-1) production,” Molecules and Cells, vol. 29, no. 3, pp. 277–282, 2010. View at Publisher · View at Google Scholar · View at Scopus
  70. T. S. R. Neerup, M. Stahlhut, J. S. Petersen et al., “ZP2307, a novel, cyclic PTH(1-17) analog that augments bone mass in ovariectomized rats,” Bone, vol. 48, no. 6, pp. 1319–1327, 2011. View at Publisher · View at Google Scholar · View at Scopus
  71. H. Wang, S. Tranguch, H. Xie, G. Hanley, S. K. Das, and S. K. Dey, “Variation in commercial rodent diets induces disparate molecular and physiological changes in the mouse uterus,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 28, pp. 9960–9965, 2005. View at Publisher · View at Google Scholar · View at Scopus
  72. A. A. Amini and L. S. Nair, “Lactoferrin: a biologically active molecule for bone regeneration,” Current Medicinal Chemistry, vol. 18, no. 8, pp. 1220–1229, 2011. View at Publisher · View at Google Scholar · View at Scopus
  73. L. J. Ignarro, R. E. Byrns, D. Sumi, F. de Nigris, and C. Napoli, “Pomegranate juice protects nitric oxide against oxidative destruction and enhances the biological actions of nitric oxide,” Nitric Oxide: Biology and Chemistry, vol. 15, no. 2, pp. 93–102, 2006. View at Publisher · View at Google Scholar · View at Scopus
  74. H. S. Parmar and A. Kar, “Medicinal values of fruit peels from Citrus sinensis, Punica granatum, and Musa paradisiaca with respect to alterations in tissue lipid peroxidation and serum concentration of glucose, insulin, and thyroid hormones,” Journal of Medicinal Food, vol. 11, no. 2, pp. 376–381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  75. H. Z. Toklu, M. U. Dumlu, Ö. Sehirli et al., “Pomegranate peel extract prevents liver fibrosis in biliary-obstructed rats,” Journal of Pharmacy and Pharmacology, vol. 59, no. 9, pp. 1287–1295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  76. M. K. N. Chidambara Murthy, G. K. Jayaprakasha, and R. P. Singh, “Studies on antioxidant activity of pomegranate (Punica granatum) peel extract using in vivo models,” Journal of Agricultural and Food Chemistry, vol. 50, no. 17, pp. 4791–4795, 2002. View at Publisher · View at Google Scholar · View at Scopus
  77. M. Shukla, K. Gupta, Z. Rasheed, K. A. Khan, and T. M. Haqqi, “Consumption of hydrolyzable tannins-rich pomegranate extract suppresses inflammation and joint damage in rheumatoid arthritis,” Nutrition, vol. 24, no. 7-8, pp. 733–743, 2008. View at Publisher · View at Google Scholar · View at Scopus
  78. M. Larrosa, A. González-Sarrías, M. J. Yáñez-Gascón et al., “Anti-inflammatory properties of a pomegranate extract and its metabolite urolithin-A in a colitis rat model and the effect of colon inflammation on phenolic metabolism,” The Journal of Nutritional Biochemistry, vol. 21, no. 8, pp. 717–725, 2010. View at Publisher · View at Google Scholar · View at Scopus
  79. C.-J. Lee, L.-G. Chen, W.-L. Liang, and C.-C. Wang, “Anti-inflammatory effects of Punica granatum Linne in vitro and in vivo,” Food Chemistry, vol. 118, no. 2, pp. 315–322, 2010. View at Publisher · View at Google Scholar · View at Scopus
  80. Z. Rasheed, N. Akhtar, A. N. Anbazhagan, S. Ramamurthy, M. Shukla, and T. M. Haqqi, “Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP kinases and NF-κB in human KU812 cells,” Journal of Inflammation, vol. 6, article 1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  81. S. M. S. Menezes, L. N. Cordeiro, and G. S. B. Viana, “Punica granatum (pomegranate) extract is active against dental plaque,” Journal of Herbal Pharmacotherapy, vol. 6, no. 2, pp. 79–92, 2006. View at Publisher · View at Google Scholar · View at Scopus
  82. L. C. de Souza Vasconcelos, M. C. Correia Sampaio, F. Correia Sampaio, and J. S. Higino, “Use of Punica granatum as an antifungal agent against candidosis associated with denture stomatitis,” Mycoses, vol. 46, no. 5-6, pp. 192–196, 2003. View at Publisher · View at Google Scholar · View at Scopus
  83. A. A. A. Ewies, “Phytoestrogens in the management of the menopause: up-to-date,” Obstetrical and Gynecological Survey, vol. 57, no. 5, pp. 306–313, 2002. View at Publisher · View at Google Scholar · View at Scopus
  84. J.-Y. Hu and T. Aizawa, “Quantitative structure-activity relationships for estrogen receptor binding affinity of phenolic chemicals,” Water Research, vol. 37, no. 6, pp. 1213–1222, 2003. View at Publisher · View at Google Scholar · View at Scopus
  85. K. D. R. Setchell, “Phytoestrogens: the biochemistry, physiology, and implications for human health of soy isoflavones,” American Journal of Clinical Nutrition, vol. 68, no. 6, pp. 1333S–1346S, 1998. View at Google Scholar · View at Scopus
  86. J. J. B. Anderson, M. Anthony, M. Messina, and S. C. Garner, “Effects of phyto-oestrogens on tissues,” Nutrition Research Reviews, vol. 12, no. 1, pp. 75–116, 1999. View at Publisher · View at Google Scholar · View at Scopus
  87. Y. Shang and M. Brown, “Molecular determinants for the tissue specificity of SERMs,” Science, vol. 295, no. 5564, pp. 2465–2468, 2002. View at Publisher · View at Google Scholar · View at Scopus
  88. K. Yao and V. C. Jordan, “Questions about tamoxifen and the future use of antiestrogens,” Oncologist, vol. 3, no. 2, pp. 104–110, 1998. View at Google Scholar · View at Scopus
  89. B. Fisher, J. Dignam, J. Bryant et al., “Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor-positive tumors,” Journal of the National Cancer Institute, vol. 88, no. 21, pp. 1529–1542, 1996. View at Publisher · View at Google Scholar · View at Scopus
  90. L. Cortesi, E. de Matteis, I. Rashid et al., “Distribution of second primary malignancies suggests a bidirectional effect between breast and endometrial cancer a population-based study,” International Journal of Gynecological Cancer, vol. 19, no. 8, pp. 1358–1363, 2009. View at Publisher · View at Google Scholar · View at Scopus
  91. I. Maru, J. Ohnishi, S. Yamaguchi, Y. Oda, K. Kakehi, and Y. Ohta, “An estrogen-like activity in pomegranate juice,” Journal of the Japanese Society For Food Science and Technology, vol. 48, no. 2, pp. 146–149, 2001. View at Google Scholar
  92. V. Brower, “Nutraceuticals: poised for a healthy slice of the healthcare market?” Nature Biotechnology, vol. 16, no. 8, pp. 728–730, 1998. View at Publisher · View at Google Scholar · View at Scopus
  93. A. Malik, “The potentials of nutraceuticals,” Pharmainfo.net, vol. 6, 2008. View at Google Scholar
  94. H. Dureja, D. Kaushik, and V. Kumar, “Developments in nutraceuticals,” Indian Journal of Pharmacology, vol. 35, no. 6, pp. 363–372, 2003. View at Google Scholar · View at Scopus
  95. F. Tezcan, M. Gültekin-Özgüven, T. Diken, B. Özçelik, and F. B. Erim, “Antioxidant activity and total phenolic, organic acid and sugar content in commercial pomegranate juices,” Food Chemistry, vol. 115, no. 3, pp. 873–877, 2009. View at Publisher · View at Google Scholar · View at Scopus
  96. Y. Li, C. Guo, J. Yang, J. Wei, J. Xu, and S. Cheng, “Evaluation of antioxidant properties of pomegranate peel extract in comparison with pomegranate pulp extract,” Food Chemistry, vol. 96, no. 2, pp. 254–260, 2006. View at Publisher · View at Google Scholar · View at Scopus
  97. S. H. Mirdehghan and M. Rahemi, “Seasonal changes of mineral nutrients and phenolics in pomegranate (Punica granatum L.) fruit,” Scientia Horticulturae, vol. 111, no. 2, pp. 120–127, 2007. View at Publisher · View at Google Scholar · View at Scopus
  98. M. Jahfar, K. K. Vijayan, and P. Azadi, “Studies on a polysaccharide from the fruit rind of Punica granatum,” Research Journal of Chemistry and Environment, vol. 7, no. 1, pp. 43–50, 2003. View at Google Scholar
  99. M. Y. Hong, N. P. Seeram, and D. Heber, “Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor,” The Journal of Nutritional Biochemistry, vol. 19, no. 12, pp. 848–855, 2008. View at Publisher · View at Google Scholar · View at Scopus
  100. R. A. DiSilvestro, D. J. DiSilvestro, and D. J. DiSilvestro, “Pomegranate extract mouth rinsing effects on saliva measures relevant to gingivitis risk,” Phytotherapy Research, vol. 23, no. 8, pp. 1123–1127, 2009. View at Publisher · View at Google Scholar · View at Scopus
  101. N. P. Seeram, M. Aviram, Y. Zhang et al., “Comparison of antioxidant potency of commonly consumed polyphenol-rich beverages in the United States,” Journal of Agricultural and Food Chemistry, vol. 56, no. 4, pp. 1415–1422, 2008. View at Publisher · View at Google Scholar · View at Scopus
  102. N. S. Kelawala and L. Ananthanarayan, “Antioxidant activity of selected foodstuffs,” International Journal of Food Sciences and Nutrition, vol. 55, no. 6, pp. 511–516, 2004. View at Publisher · View at Google Scholar · View at Scopus
  103. A. Schäfer, Z. Chovanová, J. Muchová et al., “Inhibition of COX-1 and COX-2 activity by plasma of human volunteers after ingestion of French maritime pine bark extract (Pycnogenol),” Biomedicine and Pharmacotherapy, vol. 60, no. 1, pp. 5–9, 2006. View at Publisher · View at Google Scholar · View at Scopus
  104. N. P. Seeram, L. S. Adams, S. M. Henning et al., “In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice,” The Journal of Nutritional Biochemistry, vol. 16, no. 6, pp. 360–367, 2005. View at Publisher · View at Google Scholar · View at Scopus
  105. S. Meenakshi, G. Kalpana, A. K. Khursheed, and M. H. Tariq, “Bioavailable constituents/metabolites of pomegranate (Punica granatum L) preferentially inhibit COX2 activity ex vivo and IL-1beta-induced PGE2 production in human chondrocytes in vitro,” Journal of Inflammation, vol. 13, no. 5, p. 9, 2008. View at Google Scholar